Patents by Inventor Colin A. Mackenzie

Colin A. Mackenzie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230306533
    Abstract: Implementations of the disclosed subject matter may provide a method to receive, at a server that includes a state machine, at least a first zip code and a first energy utility name of a first user to enroll in a community solar energy generating system. The server may generate a first compilation of data that includes the received first zip code, the received first energy utility, a determined first geographic location, and the one or more first regulatory requirements. The state machine may be changed to a first state based on the first compilation of data received via an Application Program Interface (API). The server may generate a first interface to be displayed to the first user based on the first state of the state machine. The server may receive responses to one or more first inputs received by the first interface.
    Type: Application
    Filed: March 23, 2022
    Publication date: September 28, 2023
    Inventors: Brendan Brown, Colin MacKenzie
  • Publication number: 20230131132
    Abstract: Various example embodiments for supporting security for containerized applications may be configured to support security for containerized applications deployed to customer devices. Various example embodiments for supporting security for containerized applications that are deployed to customer devices may be configured to properly secure and validate containerized applications that are deployed to customer devices.
    Type: Application
    Filed: October 21, 2021
    Publication date: April 27, 2023
    Inventors: Gino Dion, Steve Boutilier, Chris McAloney, Colin MacKenzie
  • Publication number: 20220240113
    Abstract: An apparatus and method involved monitoring performance indicators of connections of one or more terminal devices communicating with mesh access points of a wireless mesh network, storing results of the monitoring as monitoring results, determining, based on the stored monitoring results, whether one or more of the terminal devices are experiencing service quality below a given threshold for a given amount of time and reporting the results of the determining.
    Type: Application
    Filed: January 20, 2022
    Publication date: July 28, 2022
    Applicant: Nokia Technologies OY
    Inventors: Gino DION, Chris MCALONEY, Colin MACKENZIE, Steve BOUTILIER
  • Patent number: 11191493
    Abstract: A method is provided for predicting that a patient will require a blood transfusion during a treatment. The method includes obtaining, on a processor, first data that indicates values for one or more parameters of a characteristic of a continuous photoplethysmographic (PPG) waveform collected during the treatment. The method further includes applying, on the processor, coefficients to the values for the one or more parameters. The method further includes determining, on the processor, second data that indicates a prediction that the patient will require the blood transfusion during the treatment based on applying the coefficients to the values for the one or more parameters. An apparatus is also provided for predicting that the patient will require the blood transfusion during the treatment.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: December 7, 2021
    Assignee: The University of Maryland, Baltimore
    Inventors: Fu-Ming Hu, Colin Mackenzie, Shiming Yang, Hegang Chen
  • Patent number: 11165519
    Abstract: A controller for a wireless communication system including multiple access points includes a processor that determines measures of mutual interference between the access points based on first information received from the access points. The processor also generates second information representing a logical visualization of the access points and the mutual interference. The controller includes a transceiver that provides the second information to an interactive display device that displays the logical visualization based on the second information. The interactive display device provides third information to the transceiver that indicates modifications to the logical visualization made by a user via the interactive display device. The processor reconfigures one or more of the access points based on the third information.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: November 2, 2021
    Assignee: Nokia Solutions and Networks Oy
    Inventors: Gino Dion, Steve Boutilier, Chris McAloney, Colin MacKenzie, Ertugrul Akyurek
  • Publication number: 20210111815
    Abstract: A controller for a wireless communication system including multiple access points includes a processor that determines measures of mutual interference between the access points based on first information received from the access points. The processor also generates second information representing a logical visualization of the access points and the mutual interference. The controller includes a transceiver that provides the second information to an interactive display device that displays the logical visualization based on the second information. The interactive display device provides third information to the transceiver that indicates modifications to the logical visualization made by a user via the interactive display device. The processor reconfigures one or more of the access points based on the third information.
    Type: Application
    Filed: October 14, 2019
    Publication date: April 15, 2021
    Inventors: Gino DION, Steve Boutilier, Chris MCALONEY, Colin MACKENZIE, Ertugrul AKYUREK
  • Publication number: 20190328338
    Abstract: A method is provided for predicting that a patient will require a blood transfusion during a treatment. The method includes obtaining, on a processor, first data that indicates values for one or more parameters of a characteristic of a continuous photoplethysmographic (PPG) waveform collected during the treatment. The method further includes applying, on the processor, coefficients to the values for the one or more parameters. The method further includes determining, on the processor, second data that indicates a prediction that the patient will require the blood transfusion during the treatment based on applying the coefficients to the values for the one or more parameters. An apparatus is also provided for predicting that the patient will require the blood transfusion during the treatment.
    Type: Application
    Filed: February 28, 2019
    Publication date: October 31, 2019
    Inventors: Fu-Ming Hu, Colin Mackenzie, Shiming Yang, Hegang Chen
  • Patent number: 10258292
    Abstract: A method is provided for predicting that a patient will require a blood transfusion during a treatment. The method includes obtaining, on a processor, first data that indicates values for one or more parameters of a characteristic of a continuous photoplethysmographic (PPG) waveform collected during the treatment. The method further includes applying, on the processor, coefficients to the values for the one or more parameters. The method further includes determining, on the processor, second data that indicates a prediction that the patient will require the blood transfusion during the treatment based on applying the coefficients to the values for the one or more parameters. An apparatus is also provided for predicting that the patient will require the blood transfusion during the treatment.
    Type: Grant
    Filed: August 12, 2014
    Date of Patent: April 16, 2019
    Assignee: University of Maryland, Baltimore
    Inventors: Fu-Ming Hu, Colin Mackenzie, Shiming Yang, Hegang Chen
  • Patent number: 9717703
    Abstract: Emulsion and emulsion preconcentrate compositions comprising omega-3 fatty acids and uses thereof are disclosed.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: August 1, 2017
    Assignee: GLAXOSMITHKLINE LLC
    Inventors: Omar Abdelfattah Abu-Baker, Donald Colin MacKenzie, Rennan Pan
  • Publication number: 20160183885
    Abstract: A method is provided for predicting that a patient will require a blood transfusion during a treatment. The method includes obtaining, on a processor, first data that indicates values for one or more parameters of a characteristic of a continuous photoplethysmographic (PPG) waveform collected during the treatment. The method further includes applying, on the processor, coefficients to the values for the one or more parameters. The method further includes determining, on the processor, second data that indicates a prediction that the patient will require the blood transfusion during the treatment based on applying the coefficients to the values for the one or more parameters. An apparatus is also provided for predicting that the patient will require the blood transfusion during the treatment.
    Type: Application
    Filed: August 12, 2014
    Publication date: June 30, 2016
    Applicant: The University of Maryland, Baltimore
    Inventors: Peter Fuming HU, Colin MACKENZIE, Shiming YANG, Hegang CHEN
  • Patent number: 8236345
    Abstract: A pharmaceutical composition, comprising a thiazolidinedione, such as Compound (I), metformin hydrochloride and a pharmaceutically acceptable carrier, wherein the thiazolidinedione and metformin hydrochloride are each dispersed within its own pharmaceutically acceptable carrier in the pharmaceutical composition and the use of such a composition in medicine.
    Type: Grant
    Filed: July 18, 2007
    Date of Patent: August 7, 2012
    Assignee: SmithKline Beecham Limited
    Inventors: Karen Lewis, Nicola Jayne Lilliott, Donald Colin MacKenzie
  • Publication number: 20080206336
    Abstract: An oral dosage form comprising an erodable core, which core comprises Compound A or a pharmaceutically acceptable salt or solvate thereof and another antidiabetic agent, the core having a coating with one or more openings, characterised in that the coating is erodable under predetermined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine.
    Type: Application
    Filed: August 9, 2004
    Publication date: August 28, 2008
    Applicant: SB PHARMCO PURERTO RICO INC. The Prentice Hall Corp. System of P.R. Inc.
    Inventors: Peter John Coles, Donald Colin Mackenzie, Paul Norman Mudd
  • Publication number: 20060286113
    Abstract: A novel single domain antibody AFAI and fragments thereof which has specific affinity for binding to carcinoma, and especially lung carcinoma. This antibody, and portions thereof, can be used, inter alia in the diagnosis and treatment of carcinoma.
    Type: Application
    Filed: May 25, 2006
    Publication date: December 21, 2006
    Inventors: Colin Mackenzie, Jianbing Zhang, Thanh-Dung Nguyen, Qinggang Li, Kien Mai
  • Publication number: 20050164180
    Abstract: Phage display libraries are taught in which the recombinant phage population displays a plurality of potential binding fragments having preferred characteristics of solubility and/or intermolecular interaction. Also taught are methods of biasing display libraries to produce variants which more closely approximate the preferred characteristics of the parental binding fragment.
    Type: Application
    Filed: December 21, 2001
    Publication date: July 28, 2005
    Inventors: Jamshid Tanha, Joycelyn Entwistle, Saran Narang, Michael Dan, Colin Mackenzie, Howard Kaplan, Carole Grad
  • Publication number: 20050060211
    Abstract: Techniques for delivering data for coordinating multiple party use of a facility include producing conditions data by measuring without human intervention current condition of a facility that is used by multiple human parties. Availability data that indicates present or future availability for the facility is generated based at least in part on the conditions data. Coordination data based at least in part on the availability data is presented for the parties. These techniques allow rapid dynamic adaptation to changing status of a high-value facility while being less reliant on varied and subjective human motivations for reporting status changes. Undue exposure of sensitive information can be avoided by deriving less detailed views from high-resolution images of the facility and its users. Coordination data can be projected directly onto, and manual input can be derived from, a magnetic white board currently used for coordination at many facilities.
    Type: Application
    Filed: August 26, 2004
    Publication date: March 17, 2005
    Inventors: Yan Xiao, Fu Hu, F. Seagull, Colin MacKenzie
  • Publication number: 20040087629
    Abstract: A novel pharmaceutical compound 5-[4-2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione L(+) Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.
    Type: Application
    Filed: July 16, 2003
    Publication date: May 6, 2004
    Inventors: Berndette Marie Choudary, Andrew Simon Craig, Tim Chien Ting Ho, Donald Colin Mackenzie, Deirdre O'Keeffe
  • Publication number: 20040081697
    Abstract: A pharmaceutical composition, which composition comprises: an insulin sensitiser and another antidiabetic agent and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of at least one of the insulin sensitiser and the other antidiabetes agent, and the use of such composition in medicine.
    Type: Application
    Filed: October 21, 2003
    Publication date: April 29, 2004
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Karen Lewis, Nicola Jayne Lilliott, Donald Colin MacKenzie, Vincenzo Re
  • Publication number: 20040048899
    Abstract: A novel pharmaceutical compound 5-[4-[2-(N-methyl-N-(2-pyridyl)amino) ethoxy]benzyl]thiazolidine-2,4-dione D(−) Tartrate or a solvate thereof, a process for preparing such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine
    Type: Application
    Filed: July 30, 2003
    Publication date: March 11, 2004
    Inventors: Bernadette Marie Choudary, Andrew Simon Craig, Tim Chien Ting Ho, Donald Colin Mackenzie, Deirdre O'Keeffe
  • Patent number: 4890174
    Abstract: A very high capacity, closed-loop Winchester disk drive system particularly suited to meet the demands of a portable computer system is disclosed. The micro-Winchester disk is a Winchester disk of 95 mm in diameter. The disk drive system of the present invention, by virtue of its small size and vibration isolation, is ideally suited for use in portable computer systems. The micro-Winchester disk drive system was developed to store data at a density in excess of 1000 tracks per inch utilizing a closed-loop rotary voice coil positioning mechanism. This disk drive system provides fast access data storage for use with small business computers, terminals and microprocessor-based systems, portable or otherwise, and many other areas where compact, rugged, and lightweight hard disk storage is required. The disk drive system of the present invention normally utilizes between two and four hard disks, such as Winchester disks, with one disk containing a dedicated servo surface.
    Type: Grant
    Filed: March 18, 1987
    Date of Patent: December 26, 1989
    Assignee: Rodime PLC
    Inventors: Brian D. Chalmers, Colin A. Mackenzie, Kishore K. Kapoor
  • Patent number: RE39384
    Abstract: A compound of formula (I): or a tautomeric form thereof, wherein: R1 represents a hydrogen atom, C1-12 alkyl, C1-12 alkoxy, C1-12 alkylcarbonyl or arylC1-12 alkyl; A1 represents hydrogen or 1 to 4 optional substituents selected from the group consisting of: C1-12 alkyl, C1-12 alkoxy, aryl, and halogen; aryl represents phenyl or naphthyl optionally substituted with up to five groups selected from halogen, C1-12 alkyl, phenyl, C1-12 alkoxy, haloC1-12 alkyl, hydroxy, nitro, C1-12 alkoxycarbonyl, C1-12 alkoxycarbonyl C1-12 alkyl, C1-12 alkoxycarbonyloxy, or C1-12 alkylcarbonyl: A2 represents a benzene ring having 1 to 3 optional substituents selected from hydrogen, halogen, C1-12 alkyl, C1-12 alkoxy; and M? represents a counter-ion other than the maleate ion.
    Type: Grant
    Filed: March 17, 2003
    Date of Patent: November 7, 2006
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Philip Christopher Buxton, Donald Colin Mackenzie